IPO Premiums
IPO calendar
VBVILINBIOListed

Vilin Bio Med Limited

Fixed Price IPO · NSE

Price band
₹30 - ₹30
Lot size
4,000 shares
Issue amount
₹12 cr
Total subscription
2.82×
Current price₹60
Listing price ₹30
Watch live price ↗
Opens
16 Jun 2023
Closes
21 Jun 2023
Allotment
26 Jun 2023
Listing
30 Jun 2023

Offer at a glance

Issue overview

Issue size
40,00,000 shares
Face value
₹10 per share
Minimum investment
₹1,20,000
Fresh issue
₹12 cr
Offer for sale
₹0 cr
Registrar
Bigshare Services Private Limited
Listing exchange
NSE
Maximum investment
₹1,20,000
Issue type
Fixed Price IPO
Shares before issue
99,50,000
Shares after issue
1,39,50,000

Lot sizes

CategoryLotsSharesAmount
RETAIL14,000₹1,20,000
HNI28,000₹2,40,000

Share reservation

Market Maker5.2%
NII (HNI)47.4%
RETAIL47.4%

Subscription & GMP

Subscription by category

Total subscribed2.82×

Missing multiples are calculated from bids and offered shares when available.

NIB1.48×
RETAIL4.02×

GMP history

00.5120 Mar: ₹011 Nov: ₹0
20 Mar₹011 Nov

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
RETAIL624.12
NIB5.387.93

Financial performance

Company financials

In Lakhs · Reported periods may include interim results.

Revenue & profitIn Lakhs
05001,0001,5002,000Dec 2022 · Revenue: 903.43Dec 2022 · Profit after tax: 128.08Dec 2022Mar 2022 · Revenue: 1,121.91Mar 2022 · Profit after tax: 3.35Mar 2022Mar 2021 · Revenue: 1,171.88Mar 2021 · Profit after tax: 12.13Mar 2021Mar 2020 · Revenue: 1,682.41Mar 2020 · Profit after tax: 16.22Mar 2020
RevenueProfit after tax

Key performance indicators

MetricValues
EPS0.1
ROE14.76
ROCE8.58
RONW1.15
PRE IPO(PE)24.59
POST IPO(PE)0

Values and labels as reported in the issue data.

Company information

Company profile

Incorporated in 2005, Vilin Bio Med Limited is engaged in the domestic manufacturing of pharmaceutical products, supplying in bulk to pharmaceutical manufacturers, marketers, and traders who distribute them to end customers. The company’s product range includes Oral Liquids (Syrups, Suspensions, Dry Powders – both βeta and Non-βeta-Lactam), Tablets and Capsules (βeta and Non-βeta-Lactam), External Preparations, and Dry Powders. Vilin Bio Med operates its R&D center and manufacturing facility in Roorkee, Uttarakhand, ensuring quality and innovation in production. The company reported revenue of ₹1,121.91 lakhs in FY2022 and ₹1,171.88 lakhs in FY2021.

Promoters

Viswa Prasad Sadhanala

Sadhanala Venkata Rao

D. Srinivasa Reddy

Ramesh Reddy Sama

Registrar & documents

Lead manager

Inventure Merchant Banker Services Private Limited

Registered office

Sy.No.115/GF/J, Hanumanji Colony, Brig Sayeed Road, Bowempally, Secunderabad – 500003

+91 40 7961 8843

[email protected]Company website ↗

Understanding VILINBIO IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.